Davide Campari-Milano

Q2 FY24 – Campari has caught the flu

01/08/24 -"Although Campari’s results have been relatively resilient against a backdrop of soft market dynamics, the lack of sunshine leading to a negative mix is weighing on the Italian company. ..."

PDF page sample
Pages
55
Language
English
Published on
01/08/24
Download
You may also be interested by these reports :
25/06/25
Kerry Group (Add; Ireland), a global leader in the Taste & Nutrition innovation space, is strategically positioned to benefit from the accelerating ...
19/06/25
Long-term shareholder MIBA Genossenschaft placed a 2% stake via accelerated bookbuilding
17/06/25
We have updated our model following the FY24/25 results to reflect the current challenging environment, marked by ongoing uncertainties and the ...
04/06/25
Remy Cointreau’s FY24/25 results met expectations. The company withdrew its mid-term guidance but expressed optimism regarding inventory ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO